Tackling frailty and functional decline: Background of the action group A3 of the European innovation partnership for active and healthy ageing.

Abstract:

:Ageing populations represent a challenge to the sustainability of current healthcare systems. The need to balance these demographic changes with gains in healthy life years and quality of life (QoL) constitutes an additional challenge. Aware of this, the European Commission (EC) launched the European Innovation Partnership on Active and Healthy Ageing (EIPonAHA) in 2012. The EIPonAHA is an interdisciplinary and cross-sector initiative involving more than 3000 partners with two specific objectives: to increase the healthy life expectancy of Europeans by two years by 2020, while increasing their QoL. The initiatives of the EIPonAHA have been organized according to six thematic action groups (AGs), with the A3 group targeting areas relating to the prevention of functional decline and frailty. In addition to the good practices of partners, there are several on-going collaborative works. The involvement of the EC includes support through an elaborated research programme in which the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) and the Directorate-General for Communications Networks, Content and Technology (DG CONNECT) are the main funding bodies. Screening approaches and preventive interventions constitute most of the initiatives within the A3 AG. Partners are distributed across five sub-groups according to good practices: i) cognitive decline, ii) food and nutrition, iii) physical activity, iv) caregivers, and v) frailty and functional decline. Regular updates of the progression of both good practices and collaborative works are presented in A3 AG meetings. The 2017 meeting in Valencia, Spain, showcased in this paper, provides an up-to-date overview of the current status of A3 activities.

journal_name

Maturitas

journal_title

Maturitas

authors

Cano A,Dargent G,Carriazo A,López-Samaniego L,Apostolo J,Campos E,Holland C,Varela-Nieto I,Luz Sánchez-Sánchez M,Illario M,Iaccarino G,Roller RE,Goossens E,Vollenbroek-Hutten M,Pais S,Schena F,Musian D,Alvino S,Maggio

doi

10.1016/j.maturitas.2018.06.009

subject

Has Abstract

pub_date

2018-09-01 00:00:00

pages

69-73

eissn

0378-5122

issn

1873-4111

pii

S0378-5122(18)30366-9

journal_volume

115

pub_type

杂志文章,评审
  • Ophthalmic complaints as a climacteric symptom.

    abstract::The menopausal syndrome is characterized by a variety of emotional and physical symptoms of varying intensity. A total of 1287 women who attended the Outpatient Department for Climacteric Symptoms and Osteoporosis Prophylaxis (1st Department of Gynaecology and Obstetrics, University of Vienna Medical School) constitut...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/0378-5122(91)90141-c

    authors: Metka M,Enzelsberger H,Knogler W,Schurz B,Aichmair H

    更新日期:1991-12-01 00:00:00

  • Heart disease and gender in mass print media.

    abstract::Heart disease is a major cause of death, disease and disability in the developed world for both men and women. Women appear to be under-diagnosed and treated both because they fail to visit the doctor or hospital with relevant symptoms and because doctors tend to dismiss the seriousness of women's symptoms of heart di...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/j.maturitas.2009.11.019

    authors: Clarke J

    更新日期:2010-03-01 00:00:00

  • Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.

    abstract:OBJECTIVES:The aim of the present study was to evaluate the effects of low doses of hormone replacement therapy (HRT) in normal young postmenopausal women. METHODS:In an open trial healthy, non-obese postmenopausal women received for 2 years a low-dose continuous combined HRT (LD-HRT) containing 1mg estradiol+0.5 mg n...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/j.maturitas.2007.10.007

    authors: Gambacciani M,Cappagli B,Ciaponi M,Pepe A,Vacca F,Genazzani AR

    更新日期:2008-01-20 00:00:00

  • The influence of Nos3 polymorphisms on age at menarche and natural menopause.

    abstract:OBJECTIVE:Deficiency of the gene encoding endothelial nitric oxide synthase, i.e. Nos3, has been reported to be associated with late menarche, reduced ovulation rates, fewer deliveries, and earlier onset of menopause in a mouse model. METHODS:We assessed the Glu298Asp and the T-786C polymorphisms of Nos3 in 87 consecu...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/j.maturitas.2004.01.004

    authors: Worda C,Walch K,Sator M,Eppel W,Tempfer CB,Schneeberger C,Huber JC,Hefler LA

    更新日期:2004-10-15 00:00:00

  • Breast cancer molecular subtypes--modern therapeutic concepts for targeted therapy of a heterogeneous entity.

    abstract::Within the last decade, breast cancer is increasingly understood as a heterogeneous disease comprising distinct entities that vary significantly with regard to molecular biology and clinical features. Despite impressive advances in the treatment of patients with breast cancer, not all patients derive equal benefits fr...

    journal_title:Maturitas

    pub_type: 杂志文章,评审

    doi:10.1016/j.maturitas.2012.08.006

    authors: Liedtke C,Kiesel L

    更新日期:2012-12-01 00:00:00

  • Effects of estrogen replacement therapy on natriuretic peptides and blood pressure.

    abstract:OBJECTIVE:Estrogen replacement therapy (ERT) has been reported to affect blood pressure. Since natriuretic peptides have natriuretic and vasodilatory activity and also inhibit the renin-angiotensin-aldosterone system and lower blood pressure, it was hypothesized that the changes in blood pressure effected by ERT might ...

    journal_title:Maturitas

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/S0378-5122(03)00279-2

    authors: Karjalainen AH,Ruskoaho H,Vuolteenaho O,Heikkinen JE,Bäckström AC,Savolainen MJ,Kesäniemi YA

    更新日期:2004-03-15 00:00:00

  • Menopausal hormone therapy use in relation to breast cancer incidence in 11 European countries.

    abstract:INTRODUCTION:The use of menopausal hormone therapy (MHT) has decreased in many countries in the past 10 years. This is a consequence of the initial publication of the results of the Women's Health Initiative (WHI) randomized trial of estrogen plus progestin. In various countries, further studies then analyzed the incid...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/j.maturitas.2015.11.010

    authors: Antoine C,Ameye L,Paesmans M,de Azambuja E,Rozenberg S

    更新日期:2016-02-01 00:00:00

  • Postmenopausal hormone therapy and mammographic breast density.

    abstract:OBJECTIVE:The aim of this study was to evaluate the effects of different types of hormone replacement therapy (HRT) on mammographic density. MATERIALS AND METHODS:In a prospective 1-year study, 103 postmenopausal women were randomized to receive tibolone 2.5 mg/die, continuous conjugated equine estrogens 0.625 mg/die ...

    journal_title:Maturitas

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.maturitas.2005.02.010

    authors: Marchesoni D,Driul L,Ianni A,Fabiani G,Della Martina M,Zuiani C,Bazzocchi M

    更新日期:2006-01-10 00:00:00

  • Genetics and epigenetics of osteoarthritis.

    abstract::Osteoarthritis (OA) is a common age-related disease that affects the tissues of the synovial joint, leading to loss of function and pain. It impacts on both patient morbidity and mortality. It is a complex, polygenic disease that lacks any large-effect susceptibility loci. Instead, OA susceptibility alleles individual...

    journal_title:Maturitas

    pub_type: 杂志文章,评审

    doi:10.1016/j.maturitas.2011.12.001

    authors: Reynard LN,Loughlin J

    更新日期:2012-03-01 00:00:00

  • Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer.

    abstract:OBJECTIVES:To examine the effect of Cimicifuga racemosa (CR BNO 1055) on hot flushes caused by tamoxifen adjuvant therapy in young premenopausal breast cancer survivors. This treatment presents an off-label use of CR BNO 1055. METHODS:Between May 1999 and December 2001, we accrued 136 breast cancer survivors aged 35-5...

    journal_title:Maturitas

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0378-5122(02)00349-3

    authors: Hernández Muñoz G,Pluchino S

    更新日期:2003-03-14 00:00:00

  • Linking the menopause rating scale to the International classification of functioning, disability and health - A first step towards the implementation of the EMAS menopause health care model.

    abstract:OBJECTIVES:To link the Menopause Rating Scale (MRS-II) to the International Classification of Functioning, Disability and Health (ICF) and present a clinical application of an ICF-based tool. STUDY DESIGN:The MRS-II was linked to the corresponding ICF category. The linked items were used to generate an ICF Categorical...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/j.maturitas.2018.10.003

    authors: Zangger M,Poethig D,Meissner F,von Wolff M,Stute P

    更新日期:2018-12-01 00:00:00

  • Clinical profile of Org OD 14.

    abstract::The clinical profile of Org OD 14 ((7 alpha,17 alpha)-17-hydroxy-7-methyl-19-norpregn-5 (10)-en-20-yn-3-one) is remarkable in that the compound demonstrates simultaneous weak oestrogenic, androgenic and progestational activity after oral administration to animals. It was therefore studied to evaluate its efficacy in t...

    journal_title:Maturitas

    pub_type: 临床试验,杂志文章

    doi:10.1016/0378-5122(87)90038-7

    authors: Tax L,Goorissen EM,Kicovic PM

    更新日期:1987-01-01 00:00:00

  • Plasma orexin A levels in recently menopausal women during and 3 years following use of hormone therapy.

    abstract:OBJECTIVE:Alterations in sleep quality and metabolism during menopause are improved by menopausal hormone therapy (MHT). The mechanisms mediating these effects remain unclear. Orexin A (OxA) is a neuro-peptide that regulates sleep/wakefulness, food intake and metabolism. This study examined changes in plasma OxA levels...

    journal_title:Maturitas

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.maturitas.2017.01.016

    authors: Cintron D,Beckman JP,Bailey KR,Lahr BD,Jayachandran M,Miller VM

    更新日期:2017-05-01 00:00:00

  • Therapeutic targets for premature ejaculation.

    abstract::Premature ejaculation (PE) is the most common male sexual complaint, and may exert a profound negative impact on the man's life and partnership. Using currently available treatment alternatives (e.g., selective serotonin uptake inhibitor, agents acting locally on the penis), PE can be treated in most, but not all pati...

    journal_title:Maturitas

    pub_type: 杂志文章,评审

    doi:10.1016/j.maturitas.2011.06.007

    authors: Andersson KE,Abdel-Hamid IA

    更新日期:2011-09-01 00:00:00

  • A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.

    abstract::From a longitudinal prospective study, 160 women with spontaneous menopause and without steroid medication were followed during the transition from pre- to postmenopause. After 12 years 152 women were still participating in the study. Blood samples were drawn every 6 months until 1 year after the menopause and every 1...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/j.maturitas.2008.09.010

    authors: Rannevik G,Jeppsson S,Johnell O,Bjerre B,Laurell-Borulf Y,Svanberg L

    更新日期:2008-09-01 00:00:00

  • The climacteric among South-American women, who immigrated to Sweden and age-matched Swedish women.

    abstract::Forty-nine immigrated South-American (SA) and 48 Swedish women, aged 42-67 years, were studied in a comparative semi-structured interview survey, concerning the climacteric and its treatment. The mean age at natural menopause was 47 for the South-American women and 50 for the Swedish women. The prevalence of moderate ...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/0378-5122(94)00855-2

    authors: Nedstrand E,Ekseth U,Lindgren R,Hammar M

    更新日期:1995-01-01 00:00:00

  • The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study.

    abstract:OBJECTIVES:Vaginal atrophy (VA) is a chronic medical condition. It is managed unsatisfactorily, despite its high prevalence and negative impact on female quality of life. In order to meet their needs, it would be useful to know what women perceive to be the most bothersome symptom (MBS) of VA. STUDY DESIGN:Cross-secti...

    journal_title:Maturitas

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.maturitas.2017.11.007

    authors: Palma F,Xholli A,Cagnacci A,as the writing group of the AGATA study.

    更新日期:2018-02-01 00:00:00

  • Cardiovascular disease prevention in women: Impact of dietary interventions.

    abstract::In Western countries, cardiovascular disease is the leading cause of death in women. Prevalence of risk factors and clinical presentation are different in men and women and it is important to take these differences into account in both prevention and treatment. A healthy diet can substantially reduce cardiovascular ri...

    journal_title:Maturitas

    pub_type: 杂志文章,评审

    doi:10.1016/j.maturitas.2009.02.003

    authors: Hoekstra T,Beulens JW,van der Schouw YT

    更新日期:2009-05-20 00:00:00

  • Long-term compliance of continuous combined estrogen and progestogen replacement in postmenopausal women.

    abstract::The occurrence of uterine bleeding usually associated with hormonal replacement therapy is not acceptable for many women. Our objective was to review data on compliance and bleeding patterns in 70 postmenopausal women on oral replacement with estradiol 2 mg, estriol 1 mg, and norethisterone acetate 1 mg daily administ...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/0378-5122(96)01048-1

    authors: Dören M,Schneider HP

    更新日期:1996-10-01 00:00:00

  • A review of select vitamins and minerals used by postmenopausal women.

    abstract:OBJECTIVES:The purpose of this review is to summarize the effectiveness of select vitamins, minerals and trace elements in postmenopausal women for their effects on bone health, cardiovascular health, breast cancer, cognition and vasomotor symptoms. METHODS:Review of the relevant literature and results from recent cli...

    journal_title:Maturitas

    pub_type: 杂志文章,评审

    doi:10.1016/j.maturitas.2010.06.003

    authors: Dennehy C,Tsourounis C

    更新日期:2010-08-01 00:00:00

  • Stopping ovarian cancer screening in BRCA1/2 mutation carriers: effects on risk management decisions & outcome of risk-reducing salpingo-oophorectomy specimens.

    abstract:OBJECTIVE:Ovarian cancer screening (OCS) for BRCA1/2 mutation carriers was stopped in our family cancer clinic in 2009 because of its ineffectiveness. The study objective was to investigate the effect of stopping OCS on the timing and uptake of risk-reducing salpingo-oophorectomy (RRSO) and on the percentage of occult ...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/j.maturitas.2014.12.009

    authors: van Driel CM,de Bock GH,Arts HJ,Sie AS,Hollema H,Oosterwijk JC,Mourits MJ

    更新日期:2015-03-01 00:00:00

  • Skin collagen changes in post-menopausal women receiving oestradiol gel.

    abstract::Sixteen post-menopausal women who had never previously received any hormonal treatment applied Oestrogel cream 1.5 mg/day percutaneously for 1 yr. Skin biopsies were taken from the abdomen and from the lateral aspect of the thigh at 0, 3, 6 and 12 mth, and the changes in skin collagen content were noted. The abdominal...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/0378-5122(87)90045-4

    authors: Brincat M,Versi E,O'Dowd T,Moniz CF,Magos A,Kabalan S,Studd JW

    更新日期:1987-04-01 00:00:00

  • Peyronie's disease: review and recent advances.

    abstract::Peyronie's disease is an incurable, sexually debilitating fibrotic disease of the penis that results in penile curvature, coital failure, and significant psychological stress for patients and their partners. Appropriate treatment should be individualized and tailored to the patient's goals and expectations, disease hi...

    journal_title:Maturitas

    pub_type: 杂志文章,评审

    doi:10.1016/j.maturitas.2014.05.024

    authors: Langston JP,Carson CC 3rd

    更新日期:2014-08-01 00:00:00

  • Lifestyle and health factors associated with stress urinary incontinence in Japanese women.

    abstract:OBJECTIVES:Studies focusing on lifestyle and health factors and stress urinary incontinence (SUI) are scarce in Japan. The aim of this study is to examine the association of lifestyle and health factors in SUI. METHODS:Study subjects were retrieved from Japanese women participating in a health checkup program provided...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/j.maturitas.2010.04.002

    authors: Masue T,Wada K,Nagata C,Deguchi T,Hayashi M,Takeda N,Yasuda K

    更新日期:2010-07-01 00:00:00

  • Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen/progestin therapy: a 2-year prospective study.

    abstract:OBJECTIVE:To re-examine the minimal effective dose of conjugated estrogen (CEE)-progestin hormone replacement on postmenopausal bone loss. DESIGN:A 2-year, prospective, open label, randomized study. SETTING:Department of Obstetrics and Gynecology of a university hospital. PARTICIPANTS:Fifty-two postmenopausal or oop...

    journal_title:Maturitas

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0378-5122(97)01110-9

    authors: Mizunuma H,Okano H,Soda M,Kagami I,Miyamoto S,Tokizawa T,Honjo S,Ibuki Y

    更新日期:1997-05-01 00:00:00

  • The age and symptomatology of natural menopause among United Arab Emirates women.

    abstract:OBJECTIVES:To determine the median age of natural menopause in United Arab Emirates women, the factors affecting that age and the prevalence of climacteric symptoms amongst those women. METHODS:A population-based survey was conducted on a community sample of United Arab Emirates women who had had natural menopause def...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/s0378-5122(98)00010-3

    authors: Rizk DE,Bener A,Ezimokhai M,Hassan MY,Micallef R

    更新日期:1998-06-17 00:00:00

  • Effect of hormone replacement therapy on uterine fibroids in postmenopausal women--a 3-year study.

    abstract:OBJECTIVE:The aim of this prospective 3-year clinical study was to examine the effect of hormone replacement therapy (HRT) on uterine fibroid growth among postmenopausal women. METHODS:Thirty-seven postmenopausal women with uterine solitary fibroids were recruited randomly for HRT in a 3-year program. All participants...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/s0378-5122(02)00159-7

    authors: Yang CH,Lee JN,Hsu SC,Kuo CH,Tsai EM

    更新日期:2002-09-30 00:00:00

  • Factors predictive of the perceived osteoporosis-fracture link in fragility fracture patients.

    abstract:OBJECTIVE:Given the asymptomatic nature of osteoporosis, a fragility fracture provides an opportunity to make the issue of osteoporosis relevant to patients. Patients who link their fragility fracture with osteoporosis are more likely to initiate osteoporosis treatment, yet to date, we know little about who is likely t...

    journal_title:Maturitas

    pub_type: 杂志文章

    doi:10.1016/j.maturitas.2013.07.014

    authors: Sujic R,Gignac MA,Cockerill R,Beaton DE

    更新日期:2013-10-01 00:00:00

  • The mechanisms tumor cells utilize to evade the host's immune system.

    abstract::The immune system plays an essential role in the tumor progression; not only can it inhibit tumor growth but it can also promote tumor growth by establishing a favorable environment. Tumor cells utilize several strategies to evade the host's immune system, including expression of immunosuppressive molecules such as PD...

    journal_title:Maturitas

    pub_type: 杂志文章,评审

    doi:10.1016/j.maturitas.2017.04.014

    authors: Kuol N,Stojanovska L,Nurgali K,Apostolopoulos V

    更新日期:2017-11-01 00:00:00

  • Effect of postmenopausal estrogen therapy on diastolic blood pressure and bodyweight.

    abstract::The effect of two forms of exogenous estrogen and a placebo on diastolic blood pressure and bodyweight was evaluated in 50 oophorectomized women. There was no significant change in bodyweight on any form of treatment, nor was there any significant elevation in mean diastolic blood pressure. However, 2 out of 49 female...

    journal_title:Maturitas

    pub_type: 临床试验,杂志文章

    doi:10.1016/0378-5122(78)90003-8

    authors: Utian WH

    更新日期:1978-06-01 00:00:00